Editorials

• Disease Management Programs in Heart Failure: One Step Beyond Pharmacology

  Daniel Ferrante

  Rev Esp Cardiol. 2011;64:258-9

• Multiple Risk Factor Intervention to Prevent Cardiovascular Disease. A High Powered and Evidence Based Approach

  Thomas Guterbaum, Peter Gæde

  Rev Esp Cardiol. 2011;64:173-4

• Risk Assessment in Critically Ill Patients Awaiting Transplantation: a Step Forward

  Gautam V. Ramani, Mandeep R. Mehra

  Rev Esp Cardiol. 2011;64:175-6

• Minimal Access Surgery for Atrial Septal Defects in Children

  Pedro J. del Nido

  Rev Esp Cardiol. 2011;64:177-8

• Cardiac Magnetic Resonance Imaging and Endothelin-1: A Step Forward in the Detection of Microvascular Obstruction

  Edwin Wu, María Manuela Izquierdo Gómez

  Rev Esp Cardiol. 2011;64:89-91

• Role of a New Cardiac Catheterization Laboratory in Advancing Cardiovascular Care and Outcomes in Post-Myocardial Infarction Patients

  William E. Boden, Vipul Gupta, Alpesh Patel

  Rev Esp Cardiol. 2011;64:87-8

• Non-Invasive Imaging Tests for the Evaluation of Low Risk Patients in Chest Pain Units: Availability, Contributions and Drawbacks in Real Practice

  Michael C. Kontos

  Rev Esp Cardiol. 2011;64:92-5

• Secondary Prevention: The Ongoing Challenge

  Véronique L. Roger

  Rev Esp Cardiol. 2011;64:8-9

• Current Trends in the Classification of Sudden Cardiac Death Based on Autopsy Derived Data: A Review of Investigations Into the Etiology of Sudden Cardiac Death

  Naima Carter-Monroe, Renu Virmani

  Rev Esp Cardiol. 2011;64:10-2

• Three-dimensional Echocardiography in the Assessment of Prosthetic Valves

  Wendy Tsang, Lynn Weinert, Itzhak Kronzon, Roberto M. Lang

  Rev Esp Cardiol. 2011;64:1-7

• Quality of Life in Patients With Atrial Fibrilation

  A. John Camm

  Rev Esp Cardiol. 2010;63:1393-5

• The Importance of Discussing Living Wills With Patients With Heart Failure

  Sloan Beth Karver, Jessalyn Berger

  Rev Esp Cardiol. 2010;63:1396-8

• Clinical Inertia: Hard to Move It Forward

  William T. Branch, Stacy Higgins

  Rev Esp Cardiol. 2010;63:1399-401

• How Should We Conduct Studies on Interventions That Promote Clinically Relevant Increases in Physical Activity?

  Howard D. Sesso

  Rev Esp Cardiol. 2010;63:1232-4

• Cardiac Resynchronisation Therapy is Cost Effective

  Melanie J. Calvert, Nick Freemantle, John G.F. Cleland

  Rev Esp Cardiol. 2010;63:1230-1

• New Anticoagulants and the Future of Cardiology

  Felicita Andreotti, Teodosio Pafundi

  Rev Esp Cardiol. 2010;63:1223-9

• Use of Genetics and Transcriptomics in the Diagnosis and Treatment of Coronary Artery Disease

  Jane E. Freedman, Hannah F. Iafrati

  Rev Esp Cardiol. 2010;63:1123-6

• Cell Therapy for Heart Failure

  Andre Terzic, Carmen Perez-Terzic

  Rev Esp Cardiol. 2010;63:1117-9

• Characterizing Post-Myocardial Infarction Microvascular Obstruction by ECG: We Could Learn More From Cardiac Magnetic Resonance Imaging

  Raymond Y. Kwong, Tomas G. Neilan

  Rev Esp Cardiol. 2010;63:1120-2

• The Complexity of the Association Between Socioeconomic Status and Acute Myocardial Infarction

  Kristiina Manderbacka, Marko Elovainio

  Rev Esp Cardiol. 2010;63:1015-8